カテゴリー： QYResearch, 世界

世界のがんCDK阻害剤市場 2019年

【英語タイトル】Global Cancer CDK Inhibitors Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X04989）・商品コード：DATA909X04989
・発行会社（調査会社）：QYResearch
・発行日：2019年11月15日（※2024年版があります。お問い合わせください）
・ページ数：111
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、がんCDK阻害剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、前臨床、フェーズI、フェーズI / II、フェーズII、フェーズIIIに、用途別には、病院、診療所、その他にセグメント区分し、がんCDK阻害剤の世界市場を分析しました。


・エグゼクティブ・サマリー
・がんCDK阻害剤の世界市場概要
・がんCDK阻害剤の製造コスト構成分析
・がんCDK阻害剤の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・がんCDK阻害剤の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・がんCDK阻害剤のセグメント分析（種類別）
（前臨床、フェーズI、フェーズI / II、フェーズII、フェーズIII）
・がんCDK阻害剤のセグメント分析（用途別）
（病院、診療所、その他）
・がんCDK阻害剤の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Pfizer、Sanofi-Aventis、Merck、Eli-Lilly、Bayer Pharmaceuticals、Syros Pharmaceuticals、Piramal Life、Amgen、BioCAD、Astex、G1 Therapeutics、AnyGen Co., Ltd、Nerviano Medical Science、Cyclacel Pharmaceuticals，Inc、）
・がんCDK阻害剤の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Cancer CDK Inhibitors market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Cancer CDK Inhibitors volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cancer CDK Inhibitors market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Cancer CDK Inhibitors in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Cancer CDK Inhibitors manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Pfizer
Sanofi-Aventis
Merck
Eli-Lilly
Bayer Pharmaceuticals
Syros Pharmaceuticals
Piramal Life
Amgen
BioCAD
Astex
G1 Therapeutics
AnyGen Co., Ltd
Nerviano Medical Science
Cyclacel Pharmaceuticals，Inc

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Preclinical
Phase-I
Phase-I/II
Phase-II
Phase-III

Segment by Application
Hospitals
Clinics
Other

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Cancer CDK Inhibitors
1.1 Definition of Cancer CDK Inhibitors
1.2 Cancer CDK Inhibitors Segment by Type
1.2.1 Global Cancer CDK Inhibitors Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Preclinical
1.2.3 Phase-I
1.2.4 Phase-I/II
1.2.5 Phase-II
1.2.6 Phase-III
1.3 Cancer CDK Inhibitors Segment by Applications
1.3.1 Global Cancer CDK Inhibitors Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Cancer CDK Inhibitors Overall Market
1.4.1 Global Cancer CDK Inhibitors Revenue (2014-2025)
1.4.2 Global Cancer CDK Inhibitors Production (2014-2025)
1.4.3 North America Cancer CDK Inhibitors Status and Prospect (2014-2025)
1.4.4 Europe Cancer CDK Inhibitors Status and Prospect (2014-2025)
1.4.5 China Cancer CDK Inhibitors Status and Prospect (2014-2025)
1.4.6 Japan Cancer CDK Inhibitors Status and Prospect (2014-2025)
1.4.7 Southeast Asia Cancer CDK Inhibitors Status and Prospect (2014-2025)
1.4.8 India Cancer CDK Inhibitors Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Cancer CDK Inhibitors
2.3 Manufacturing Process Analysis of Cancer CDK Inhibitors
2.4 Industry Chain Structure of Cancer CDK Inhibitors

3 Development and Manufacturing Plants Analysis of Cancer CDK Inhibitors
3.1 Capacity and Commercial Production Date
3.2 Global Cancer CDK Inhibitors Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Cancer CDK Inhibitors
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Cancer CDK Inhibitors Production and Capacity Analysis
4.2 Cancer CDK Inhibitors Revenue Analysis
4.3 Cancer CDK Inhibitors Price Analysis
4.4 Market Concentration Degree

5 Cancer CDK Inhibitors Regional Market Analysis
5.1 Cancer CDK Inhibitors Production by Regions
5.1.1 Global Cancer CDK Inhibitors Production by Regions
5.1.2 Global Cancer CDK Inhibitors Revenue by Regions
5.2 Cancer CDK Inhibitors Consumption by Regions
5.3 North America Cancer CDK Inhibitors Market Analysis
5.3.1 North America Cancer CDK Inhibitors Production
5.3.2 North America Cancer CDK Inhibitors Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Cancer CDK Inhibitors Import and Export
5.4 Europe Cancer CDK Inhibitors Market Analysis
5.4.1 Europe Cancer CDK Inhibitors Production
5.4.2 Europe Cancer CDK Inhibitors Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Cancer CDK Inhibitors Import and Export
5.5 China Cancer CDK Inhibitors Market Analysis
5.5.1 China Cancer CDK Inhibitors Production
5.5.2 China Cancer CDK Inhibitors Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Cancer CDK Inhibitors Import and Export
5.6 Japan Cancer CDK Inhibitors Market Analysis
5.6.1 Japan Cancer CDK Inhibitors Production
5.6.2 Japan Cancer CDK Inhibitors Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Cancer CDK Inhibitors Import and Export
5.7 Southeast Asia Cancer CDK Inhibitors Market Analysis
5.7.1 Southeast Asia Cancer CDK Inhibitors Production
5.7.2 Southeast Asia Cancer CDK Inhibitors Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Cancer CDK Inhibitors Import and Export
5.8 India Cancer CDK Inhibitors Market Analysis
5.8.1 India Cancer CDK Inhibitors Production
5.8.2 India Cancer CDK Inhibitors Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Cancer CDK Inhibitors Import and Export

6 Cancer CDK Inhibitors Segment Market Analysis (by Type)
6.1 Global Cancer CDK Inhibitors Production by Type
6.2 Global Cancer CDK Inhibitors Revenue by Type
6.3 Cancer CDK Inhibitors Price by Type

7 Cancer CDK Inhibitors Segment Market Analysis (by Application)
7.1 Global Cancer CDK Inhibitors Consumption by Application
7.2 Global Cancer CDK Inhibitors Consumption Market Share by Application (2014-2019)

8 Cancer CDK Inhibitors Major Manufacturers Analysis
8.1 Pfizer
8.1.1 Pfizer Cancer CDK Inhibitors Production Sites and Area Served
8.1.2 Pfizer Product Introduction, Application and Specification
8.1.3 Pfizer Cancer CDK Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Sanofi-Aventis
8.2.1 Sanofi-Aventis Cancer CDK Inhibitors Production Sites and Area Served
8.2.2 Sanofi-Aventis Product Introduction, Application and Specification
8.2.3 Sanofi-Aventis Cancer CDK Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Merck
8.3.1 Merck Cancer CDK Inhibitors Production Sites and Area Served
8.3.2 Merck Product Introduction, Application and Specification
8.3.3 Merck Cancer CDK Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Eli-Lilly
8.4.1 Eli-Lilly Cancer CDK Inhibitors Production Sites and Area Served
8.4.2 Eli-Lilly Product Introduction, Application and Specification
8.4.3 Eli-Lilly Cancer CDK Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Bayer Pharmaceuticals
8.5.1 Bayer Pharmaceuticals Cancer CDK Inhibitors Production Sites and Area Served
8.5.2 Bayer Pharmaceuticals Product Introduction, Application and Specification
8.5.3 Bayer Pharmaceuticals Cancer CDK Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Syros Pharmaceuticals
8.6.1 Syros Pharmaceuticals Cancer CDK Inhibitors Production Sites and Area Served
8.6.2 Syros Pharmaceuticals Product Introduction, Application and Specification
8.6.3 Syros Pharmaceuticals Cancer CDK Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Piramal Life
8.7.1 Piramal Life Cancer CDK Inhibitors Production Sites and Area Served
8.7.2 Piramal Life Product Introduction, Application and Specification
8.7.3 Piramal Life Cancer CDK Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Amgen
8.8.1 Amgen Cancer CDK Inhibitors Production Sites and Area Served
8.8.2 Amgen Product Introduction, Application and Specification
8.8.3 Amgen Cancer CDK Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 BioCAD
8.9.1 BioCAD Cancer CDK Inhibitors Production Sites and Area Served
8.9.2 BioCAD Product Introduction, Application and Specification
8.9.3 BioCAD Cancer CDK Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Astex
8.10.1 Astex Cancer CDK Inhibitors Production Sites and Area Served
8.10.2 Astex Product Introduction, Application and Specification
8.10.3 Astex Cancer CDK Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 G1 Therapeutics
8.12 AnyGen Co., Ltd
8.13 Nerviano Medical Science
8.14 Cyclacel Pharmaceuticals，Inc

9 Development Trend of Analysis of Cancer CDK Inhibitors Market
9.1 Global Cancer CDK Inhibitors Market Trend Analysis
9.1.1 Global Cancer CDK Inhibitors Market Size (Volume and Value) Forecast 2019-2025
9.2 Cancer CDK Inhibitors Regional Market Trend
9.2.1 North America Cancer CDK Inhibitors Forecast 2019-2025
9.2.2 Europe Cancer CDK Inhibitors Forecast 2019-2025
9.2.3 China Cancer CDK Inhibitors Forecast 2019-2025
9.2.4 Japan Cancer CDK Inhibitors Forecast 2019-2025
9.2.5 Southeast Asia Cancer CDK Inhibitors Forecast 2019-2025
9.2.6 India Cancer CDK Inhibitors Forecast 2019-2025
9.3 Cancer CDK Inhibitors Market Trend (Product Type)
9.4 Cancer CDK Inhibitors Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Cancer CDK Inhibitors Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Cancer CDK Inhibitors
Table Global Cancer CDK Inhibitors Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Cancer CDK Inhibitors Production Market Share by Types in 2018
Figure Preclinical Product Picture
Figure Phase-I Product Picture
Figure Phase-I/II Product Picture
Figure Phase-II Product Picture
Figure Phase-III Product Picture
Table Global Cancer CDK Inhibitors Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Cancer CDK Inhibitors Consumption Market Share by Applications in 2018
Figure Hospitals
Figure Clinics
Figure Other
Figure Global Cancer CDK Inhibitors Revenue (Million USD) (2014-2025)
Figure Global Cancer CDK Inhibitors Production (K Pcs) (2014-2025)
Figure North America Cancer CDK Inhibitors Market Size (Million USD) (2014-2025)
Figure Europe Cancer CDK Inhibitors Market Size (Million USD) (2014-2025)
Figure China Cancer CDK Inhibitors Market Size (Million USD) (2014-2025)
Figure Japan Cancer CDK Inhibitors Market Size (Million USD) (2014-2025)
Figure Southeast Asia Cancer CDK Inhibitors Market Size (Million USD) (2014-2025)
Figure India Cancer CDK Inhibitors Market Size (Million USD) (2014-2025)
Table Cancer CDK Inhibitors Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Cancer CDK Inhibitors in 2018
Figure Manufacturing Process Analysis of Cancer CDK Inhibitors
Figure Industry Chain Structure of Cancer CDK Inhibitors
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Cancer CDK Inhibitors Manufacturing Plants Distribution
Table Cancer CDK Inhibitors Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Cancer CDK Inhibitors Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Cancer CDK Inhibitors Production (K Pcs) of Major Manufacturers (2014-2019)
Table Cancer CDK Inhibitors Production Market Share of Major Manufacturers (2014-2019)
Figure Cancer CDK Inhibitors Production Share by Manufacturers in 2018
Table Cancer CDK Inhibitors Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Cancer CDK Inhibitors Revenue Market Share of Major Manufacturers (2014-2019)
Figure Cancer CDK Inhibitors Revenue Share by Manufacturers in 2018
Table Cancer CDK Inhibitors Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Cancer CDK Inhibitors Production by Regions 2014-2019 (K Pcs)
Table Global Cancer CDK Inhibitors Production Market Share by Regions 2014-2019
Figure Global Cancer CDK Inhibitors Production Market Share by Regions in 2018
Table Global Cancer CDK Inhibitors Revenue by Regions 2014-2019 (Million USD)
Table Global Cancer CDK Inhibitors Revenue Market Share by Regions 2014-2019
Figure Global Cancer CDK Inhibitors Revenue Market Share by Regions in 2018
Table Global Cancer CDK Inhibitors Consumption by Regions 2014-2019 (K Pcs)
Table Global Cancer CDK Inhibitors Consumption Market Share by Regions 2014-2019
Figure North America Cancer CDK Inhibitors Production Growth Rate 2014-2019 (K Pcs)
Figure North America Cancer CDK Inhibitors Revenue Growth Rate 2014-2019 (Million USD)
Table North America Cancer CDK Inhibitors Production, Consumption Import and Export (K Pcs)
Figure Europe Cancer CDK Inhibitors Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Cancer CDK Inhibitors Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Cancer CDK Inhibitors Production, Consumption Import and Export (K Pcs)
Figure China Cancer CDK Inhibitors Production Growth Rate 2014-2019 (K Pcs)
Figure China Cancer CDK Inhibitors Revenue Growth Rate 2014-2019 (Million USD)
Table China Cancer CDK Inhibitors Production, Consumption Import and Export (K Pcs)
Figure Japan Cancer CDK Inhibitors Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Cancer CDK Inhibitors Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Cancer CDK Inhibitors Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Cancer CDK Inhibitors Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Cancer CDK Inhibitors Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Cancer CDK Inhibitors Production, Consumption Import and Export (K Pcs)
Figure India Cancer CDK Inhibitors Production Growth Rate 2014-2019 (K Pcs)
Figure India Cancer CDK Inhibitors Revenue Growth Rate 2014-2019 (Million USD)
Table India Cancer CDK Inhibitors Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Cancer CDK Inhibitors Market Share by Application (2014-2019)
Figure Global Value (Consumption) Cancer CDK Inhibitors Market Share by Application (2014-2019)
Table Pfizer Cancer CDK Inhibitors Production Sites and Area Served
Table Pfizer Cancer CDK Inhibitors Product Introduction, Application and Specification
Table Pfizer Cancer CDK Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Pfizer Cancer CDK Inhibitors Production Growth Rate (2014-2019)
Table Pfizer Cancer CDK Inhibitors Production Market Share (2014-2019)
Figure Pfizer Cancer CDK Inhibitors Revenue Market Share (2014-2019)
Table Pfizer Cancer CDK Inhibitors Main Business and Markets Served
Table Sanofi-Aventis Cancer CDK Inhibitors Production Sites and Area Served
Table Sanofi-Aventis Cancer CDK Inhibitors Product Introduction, Application and Specification
Table Sanofi-Aventis Cancer CDK Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Sanofi-Aventis Cancer CDK Inhibitors Production Growth Rate (2014-2019)
Table Sanofi-Aventis Cancer CDK Inhibitors Production Market Share (2014-2019)
Figure Sanofi-Aventis Cancer CDK Inhibitors Revenue Market Share (2014-2019)
Table Sanofi-Aventis Cancer CDK Inhibitors Main Business and Markets Served
Table Merck Cancer CDK Inhibitors Production Sites and Area Served
Table Merck Cancer CDK Inhibitors Product Introduction, Application and Specification
Table Merck Cancer CDK Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Merck Cancer CDK Inhibitors Production Growth Rate (2014-2019)
Table Merck Cancer CDK Inhibitors Production Market Share (2014-2019)
Figure Merck Cancer CDK Inhibitors Revenue Market Share (2014-2019)
Table Merck Cancer CDK Inhibitors Main Business and Markets Served
Table Eli-Lilly Cancer CDK Inhibitors Production Sites and Area Served
Table Eli-Lilly Cancer CDK Inhibitors Product Introduction, Application and Specification
Table Eli-Lilly Cancer CDK Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eli-Lilly Cancer CDK Inhibitors Production Growth Rate (2014-2019)
Table Eli-Lilly Cancer CDK Inhibitors Production Market Share (2014-2019)
Figure Eli-Lilly Cancer CDK Inhibitors Revenue Market Share (2014-2019)
Table Eli-Lilly Cancer CDK Inhibitors Main Business and Markets Served
Table Bayer Pharmaceuticals Cancer CDK Inhibitors Production Sites and Area Served
Table Bayer Pharmaceuticals Cancer CDK Inhibitors Product Introduction, Application and Specification
Table Bayer Pharmaceuticals Cancer CDK Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bayer Pharmaceuticals Cancer CDK Inhibitors Production Growth Rate (2014-2019)
Table Bayer Pharmaceuticals Cancer CDK Inhibitors Production Market Share (2014-2019)
Figure Bayer Pharmaceuticals Cancer CDK Inhibitors Revenue Market Share (2014-2019)
Table Bayer Pharmaceuticals Cancer CDK Inhibitors Main Business and Markets Served
Table Syros Pharmaceuticals Cancer CDK Inhibitors Production Sites and Area Served
Table Syros Pharmaceuticals Cancer CDK Inhibitors Product Introduction, Application and Specification
Table Syros Pharmaceuticals Cancer CDK Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Syros Pharmaceuticals Cancer CDK Inhibitors Production Growth Rate (2014-2019)
Table Syros Pharmaceuticals Cancer CDK Inhibitors Production Market Share (2014-2019)
Figure Syros Pharmaceuticals Cancer CDK Inhibitors Revenue Market Share (2014-2019)
Table Syros Pharmaceuticals Cancer CDK Inhibitors Main Business and Markets Served
Table Piramal Life Cancer CDK Inhibitors Production Sites and Area Served
Table Piramal Life Cancer CDK Inhibitors Product Introduction, Application and Specification
Table Piramal Life Cancer CDK Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Piramal Life Cancer CDK Inhibitors Production Growth Rate (2014-2019)
Table Piramal Life Cancer CDK Inhibitors Production Market Share (2014-2019)
Figure Piramal Life Cancer CDK Inhibitors Revenue Market Share (2014-2019)
Table Piramal Life Cancer CDK Inhibitors Main Business and Markets Served
Table Amgen Cancer CDK Inhibitors Production Sites and Area Served
Table Amgen Cancer CDK Inhibitors Product Introduction, Application and Specification
Table Amgen Cancer CDK Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Amgen Cancer CDK Inhibitors Production Growth Rate (2014-2019)
Table Amgen Cancer CDK Inhibitors Production Market Share (2014-2019)
Figure Amgen Cancer CDK Inhibitors Revenue Market Share (2014-2019)
Table Amgen Cancer CDK Inhibitors Main Business and Markets Served
Table BioCAD Cancer CDK Inhibitors Production Sites and Area Served
Table BioCAD Cancer CDK Inhibitors Product Introduction, Application and Specification
Table BioCAD Cancer CDK Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table BioCAD Cancer CDK Inhibitors Production Growth Rate (2014-2019)
Table BioCAD Cancer CDK Inhibitors Production Market Share (2014-2019)
Figure BioCAD Cancer CDK Inhibitors Revenue Market Share (2014-2019)
Table BioCAD Cancer CDK Inhibitors Main Business and Markets Served
Table Astex Cancer CDK Inhibitors Production Sites and Area Served
Table Astex Cancer CDK Inhibitors Product Introduction, Application and Specification
Table Astex Cancer CDK Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Astex Cancer CDK Inhibitors Production Growth Rate (2014-2019)
Table Astex Cancer CDK Inhibitors Production Market Share (2014-2019)
Figure Astex Cancer CDK Inhibitors Revenue Market Share (2014-2019)
Table Astex Cancer CDK Inhibitors Main Business and Markets Served
Table G1 Therapeutics Cancer CDK Inhibitors Production Sites and Area Served
Table AnyGen Co., Ltd Cancer CDK Inhibitors Production Sites and Area Served
Table Nerviano Medical Science Cancer CDK Inhibitors Production Sites and Area Served
Table Cyclacel Pharmaceuticals，Inc Cancer CDK Inhibitors Production Sites and Area Served
Figure Global Cancer CDK Inhibitors Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Cancer CDK Inhibitors Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Cancer CDK Inhibitors Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Cancer CDK Inhibitors Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Cancer CDK Inhibitors Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Cancer CDK Inhibitors Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Cancer CDK Inhibitors Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Cancer CDK Inhibitors Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Cancer CDK Inhibitors Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Cancer CDK Inhibitors Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Cancer CDK Inhibitors Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Cancer CDK Inhibitors Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Cancer CDK Inhibitors Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Cancer CDK Inhibitors Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Cancer CDK Inhibitors Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Cancer CDK Inhibitors by Type (2019-2025)
Table Global Consumption (K Pcs) of Cancer CDK Inhibitors by Application (2019-2025)
Table Cancer CDK Inhibitors Distributors List
Table Cancer CDK Inhibitors Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Pfizer、Sanofi-Aventis、Merck、Eli-Lilly、Bayer Pharmaceuticals、Syros Pharmaceuticals、Piramal Life、Amgen、BioCAD、Astex、G1 Therapeutics、AnyGen Co., Ltd、Nerviano Medical Science、Cyclacel Pharmaceuticals，Inc、

★調査レポート[世界のがんCDK阻害剤市場 2019年] (コード：DATA909X04989)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のがんCDK阻害剤市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のがんチューブリン阻害剤市場 2019年
    DATA909X04995 / QYResearch / 2019年11月15日 / ※本調査レポートは、がんチューブリン阻害剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ドセタキセル、トラスツズマブエムタンシン、アブラキサン、ブレンツキシマブベドチン、カバジタキセルに、用途別には、非小細胞肺がん、前立腺がん、乳がん、大腸がん、卵巣がんにセグメント区分し、がんチューブリン阻害剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・がんチューブリン阻害剤の世界市場概要 ・がんチューブリン阻害剤の製造コスト構成分析 ・がんチューブリン阻害剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・がんチューブリン阻害剤の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・がんチューブリン阻害剤のセグメント分析（種類別） （ドセタキセル、トラスツズマブエムタンシン、アブラキサン、ブレンツキシマブベドチン、カバジタキセル）...The global Cancer Tubulin Inhibitors market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Cancer Tubulin Inhibitors volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cancer Tubulin Inhibitors market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Cancer Tubulin Inhibitors in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のがんmTOR阻害剤市場 2019年
    DATA909X04992 / QYResearch / 2019年11月15日 / ※本調査レポートは、がんmTOR阻害剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アフィニトール/ Votubia、Afinitor Disperz andndash; まれな小児脳腫瘍のmTOR阻害剤、トリセル（テムシロリムス）、エバーターアンドンダッシュに、用途別には、乳がん、血液悪性腫瘍、神経内分泌腫瘍、肝細胞癌、膠芽腫にセグメント区分し、がんmTOR阻害剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・がんmTOR阻害剤の世界市場概要 ・がんmTOR阻害剤の製造コスト構成分析 ・がんmTOR阻害剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析）...The global Cancer mTOR Inhibitors market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Cancer mTOR Inhibitors volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cancer mTOR Inhibitors market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Cancer mTOR Inhibitors in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の非チロシンキナーゼ阻害剤市場 2019年
    DATA909X12094 / QYResearch / 2019年11月20日 / ※本調査レポートは、非チロシンキナーゼ阻害剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、mTOR阻害剤、RAF / MEK阻害剤、CDK阻害剤に、用途別には、肝臓がん、呼吸器がん、脳がん、その他にセグメント区分し、非チロシンキナーゼ阻害剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・非チロシンキナーゼ阻害剤の世界市場概要 ・非チロシンキナーゼ阻害剤の製造コスト構成分析 ・非チロシンキナーゼ阻害剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・非チロシンキナーゼ阻害剤の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド）...The global Non-Tyrosine Kinase Inhibitors market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Non-Tyrosine Kinase Inhibitors volume and value at global level, regional level and company level. From a global perspective, this report represents overall Non-Tyrosine Kinase Inhibitors market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Non-Tyrosine Kinase Inhibitors in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のヒストン脱アセチル化酵素阻害剤市場 2019年
    DATA909X09205 / QYResearch / 2019年11月20日 / ※本調査レポートは、ヒストン脱アセチル化酵素阻害剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、競合阻害剤、非競合阻害剤、混合阻害剤に、用途別には、精神神経学、癌治療、炎症性疾患、その他疾患にセグメント区分し、ヒストン脱アセチル化酵素阻害剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ヒストン脱アセチル化酵素阻害剤の世界市場概要 ・ヒストン脱アセチル化酵素阻害剤の製造コスト構成分析 ・ヒストン脱アセチル化酵素阻害剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ヒストン脱アセチル化酵素阻害剤の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ヒストン脱アセチル化酵素阻害剤のセグメント分析（種類別） （競合阻害剤、非競合阻害剤、混合阻害剤）...The global Histone Deacetylase Inhibitors market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Histone Deacetylase Inhibitors volume and value at global level, regional level and company level. From a global perspective, this report represents overall Histone Deacetylase Inhibitors market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Histone Deacetylase Inhibitors in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のヒストン脱アセチル化酵素（HDAC）阻害剤市場 2019年
    DATA909X09206 / QYResearch / 2019年11月20日 / ※本調査レポートは、ヒストン脱アセチル化酵素（HDAC）阻害剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ヒドロキサム酸、環状テトラペプチド、ベンズアミド、求電子ケトン、脂肪族酸に、用途別には、精神神経学、癌治療、HIV、その他にセグメント区分し、ヒストン脱アセチル化酵素（HDAC）阻害剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ヒストン脱アセチル化酵素（HDAC）阻害剤の世界市場概要 ・ヒストン脱アセチル化酵素（HDAC）阻害剤の製造コスト構成分析 ・ヒストン脱アセチル化酵素（HDAC）阻害剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ヒストン脱アセチル化酵素（HDAC）阻害剤の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ヒストン脱アセチル化酵素（HDAC）阻害剤のセグメント分析（種類別） （ヒドロキサム酸、環状テトラペプチド、ベンズアミド、求電子ケトン、脂肪族酸）...The global Histone Deacetylase(HDAC) Inhibitors market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Histone Deacetylase(HDAC) Inhibitors volume and value at global level, regional level and company level. From a global perspective, this report represents overall Histone Deacetylase(HDAC) Inhibitors market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Histone Deacetylase(HDAC) Inhibitors in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • PARP（ポリADPリボースポリメラーゼ）阻害剤の世界市場：規模・現状・予測2019-2025
    DATA909X18797 / QYResearch / 2019年11月25日 / ※当調査レポートでは、PARP（ポリADPリボースポリメラーゼ）阻害剤の世界市場について調査・分析し、PARP（ポリADPリボースポリメラーゼ）阻害剤の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（オラパリブ、タラゾパリブ）、用途別（卵巣がん、乳がん、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のPARP（ポリADPリボースポリメラーゼ）阻害剤市場動向 ・主要企業別マーケットシェア ・PARP（ポリADPリボースポリメラーゼ）阻害剤の種類別市場規模2014-2019 （オラパリブ、タラゾパリブ） ・PARP（ポリADPリボースポリメラーゼ）阻害剤の用途別市場規模2014-2019 （卵巣がん、乳がん、その他） ・PARP（ポリADPリボースポリメラーゼ）阻害剤の北米市場：主要企業・種類別/用途別市場規模 ・PARP（ポリADPリボースポリメラーゼ）阻害剤のヨーロッパ市場：主要企業・種類別/用途別市場規模...PARP inhibitors are a group of pharmacological inhibitors of the enzyme polymerase ADP ribosome (PARP).They are developed for multiple indications.PARP inhibitors can enhance the efficacy of radiotherapy, alkalization agents and platinum-based chemotherapy by inhibiting DNA damage repair and promoting apoptosis of tumor cells. Parp (Poly Adp-Ribose Polymerase) inhibitors is very effective in treating solid tumors and other diseases.Such as advanced ovarian cancer, fallopian tube cancer and primary peritoneal cancer.In 2018, the global PARP (Poly ADP-ribose Polymerase) Inhibitors market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR...
  • 世界のプロトンポンプ阻害剤市場 2019年
    DATA909X13853 / QYResearch / 2019年11月20日 / ※本調査レポートは、プロトンポンプ阻害剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、パントプラゾール、オメプラゾール、ランソプラゾール、エソメプラゾール、ラベプラゾール、デキスランソプラゾール、その他に、用途別には、病院、クリニックにセグメント区分し、プロトンポンプ阻害剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・プロトンポンプ阻害剤の世界市場概要 ・プロトンポンプ阻害剤の製造コスト構成分析 ・プロトンポンプ阻害剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・プロトンポンプ阻害剤の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・プロトンポンプ阻害剤のセグメント分析（種類別） （パントプラゾール、オメプラゾール、ランソプラゾール、エソメプラゾール、ラベプラゾール、デキスランソプラゾール、その他）...The global Proton Pump Inhibitors market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Proton Pump Inhibitors volume and value at global level, regional level and company level. From a global perspective, this report represents overall Proton Pump Inhibitors market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Proton Pump Inhibitors in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆